Brokerages Set Greenbrook TMS Inc. (NASDAQ:GBNH) Price Target at $16.10

Greenbrook TMS Inc. (NASDAQ:GBNHGet Rating) has earned a consensus rating of “Buy” from the eight ratings firms that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $16.10.

Several equities research analysts have weighed in on GBNH shares. Bloom Burton restated a “buy” rating on shares of Greenbrook TMS in a research note on Monday, April 4th. Zacks Investment Research downgraded shares of Greenbrook TMS from a “hold” rating to a “sell” rating in a research note on Friday. Canaccord Genuity Group downgraded shares of Greenbrook TMS to a “buy” rating in a research note on Monday, February 7th. Finally, Clarus Securities lowered their target price on shares of Greenbrook TMS from C$8.25 to C$7.50 in a research note on Monday, April 4th.

GBNH stock remained flat at $$2.87 during trading on Friday. 3,445 shares of the company traded hands, compared to its average volume of 16,927. The stock’s 50-day moving average price is $3.25 and its two-hundred day moving average price is $4.79. The company has a quick ratio of 1.34, a current ratio of 1.34 and a debt-to-equity ratio of 2.26. Greenbrook TMS has a 12 month low of $2.73 and a 12 month high of $13.89.

Greenbrook TMS (NASDAQ:GBNHGet Rating) last issued its quarterly earnings data on Wednesday, March 30th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.38) by $0.04. Greenbrook TMS had a negative net margin of 47.42% and a negative return on equity of 189.28%. During the same quarter last year, the business earned ($0.60) EPS. Analysts anticipate that Greenbrook TMS will post -1.21 EPS for the current fiscal year.

Several large investors have recently bought and sold shares of GBNH. Royal Bank of Canada lifted its position in Greenbrook TMS by 243.1% during the third quarter. Royal Bank of Canada now owns 6,848 shares of the company’s stock valued at $51,000 after purchasing an additional 4,852 shares during the period. AdvisorShares Investments LLC acquired a new position in Greenbrook TMS during the third quarter valued at $103,000. Rockefeller Capital Management L.P. acquired a new position in Greenbrook TMS during the third quarter valued at $109,000. Virtu Financial LLC acquired a new position in Greenbrook TMS during the fourth quarter valued at $288,000. Finally, Royce & Associates LP lifted its position in Greenbrook TMS by 8.0% during the fourth quarter. Royce & Associates LP now owns 223,500 shares of the company’s stock valued at $977,000 after purchasing an additional 16,598 shares during the period. Institutional investors and hedge funds own 16.73% of the company’s stock.

Greenbrook TMS Company Profile (Get Rating)

Greenbrook Tms, Inc engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Recommended Stories

Analyst Recommendations for Greenbrook TMS (NASDAQ:GBNH)

Receive News & Ratings for Greenbrook TMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenbrook TMS and related companies with MarketBeat.com's FREE daily email newsletter.